✦ LIBER ✦

Cisplatin and treosulfane chemotherapy in the treatment of metastatic ovarian cancer — low versus high dose

✍ Scribed by Merkle, E.; Bähr, I.; Henke, A.; Bühner, M.; Lang, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin and treosulfane chemotherapy i

✍ Merkle, E.; Bähr, I.; Henke, A.; Bühner, M.; Lang, N. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Cisplatin and treosulfane chemotherapy i

✍ Bähr, I.; Merkle, E.; Henke, A.; Bühner, M.; Lang, N. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Cisplatin and treosulfane chemotherapy i

✍ Bähr, I.; Merkle, E.; Henke, A.; Bühner, M.; Lang, N. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 148 KB

High versus low dose cisplatin in epithe

✍ Parmar, MaheshK.B.; Guthrie, David; Williams, Chris; Ghersi, Davina; Dodwell, D. 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 335 KB

A comparison of low- and high-dose cispl

✍ J Menczer; J Brenner; M Modan 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 235 KB

A comparison of low- and high-dose cispl

✍ Menczer, Joseph; Brenner, Joseph; Modan, Michaela; Ben-Baruch, Gilad; Brenner, H 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 429 KB